The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

BACKGROUND: Deutetrabenazine is approved in the USA, China, Australia, Israel, Brazil, and South Korea for the treatment of chorea associated with Huntington disease. OBJECTIVE: We aimed to evaluate the long-term safety and tolerability of deutetrabenazine for the treatment of Huntington disease. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Samuel, Testa, Claudia, Edmondson, Mary C., Goldstein, Jody, Kayson, Elise, Leavitt, Blair R., Oakes, David, O’Neill, Christine, Vaughan, Christina, Whaley, Jacquelyn, Gross, Nicholas, Gordon, Mark Forrest, Savola, Juha-Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653309/
https://www.ncbi.nlm.nih.gov/pubmed/36242718
http://dx.doi.org/10.1007/s40263-022-00956-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653309/
https://www.ncbi.nlm.nih.gov/pubmed/36242718
http://dx.doi.org/10.1007/s40263-022-00956-8

Ejemplares similares